Cargando…

What can we learn from real world studies on direct oral anticoagulants?

Detalles Bibliográficos
Autor principal:	Coppens, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612869/ https://www.ncbi.nlm.nih.gov/pubmed/28776166 http://dx.doi.org/10.1007/s12471-017-1029-5

Ejemplares similares

To learn or not to learn from real-world experience on direct oral anticoagulants in pediatric patients?
por: Streif, Werner
Publicado: (2023)

What can we learn from the islet of Joslin Medalists?
por: Yagihashi, Soroku
Publicado: (2020)

What can we learn from the history of male anorexia nervosa?
por: Zhang, Chengyuan
Publicado: (2014)

What Can We Learn from Brazil's Health Care System?
por: Qi, Yanling, et al.
Publicado: (2020)

Food safety in Vietnam: where we are at and what we can learn from international experiences
por: Nguyen-Viet, Hung, et al.
Publicado: (2017)

Brain dysfunction in sepsis: what can we learn from cerebral perfusion studies?
por: Steiner, Luzius A
Publicado: (2008)

Commentary on “Psychiatry and Cinema: What can We Learn from the Magical Screen?”
por: ANG, Qiuqing
Publicado: (2017)

What Can We Learn From Clinical Trials of Exon Skipping for DMD?
por: Lu, Qi-long, et al.
Publicado: (2014)

Poverty, protests and pandemics: what can we learn from community resilience?
por: Ahmed, Rashid, et al.
Publicado: (2021)

Look Action for Health in Diabetes trial: What we have learned in terms of real world practice and clinical trials
por: Kwok, Ching-Fai, et al.
Publicado: (2014)

Ebola Virus Disease Epidemic: What Can the World Learn and Not Learn from West Africa?
por: Azuine, Romuladus E., et al.
Publicado: (2015)

Lessons from Microbes: What Can We Learn about Equity from Unculturable Bacteria?
por: Montgomery, Beronda L.
Publicado: (2020)

What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?
por: Betensky, Marisol, et al.
Publicado: (2023)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Persistent γ-herpesvirus Infections: What Can We Learn from an Experimental Mouse Model?
por: Blackman, Marcia A., et al.
Publicado: (2002)

Screening for Familial Hypercholesterolemia in Children: What Can We Learn From Adult Screening Programs?
por: Henneman, Lidewij, et al.
Publicado: (2015)

What can we learn from Israel’s rapid roll out of COVID 19 vaccination?
por: McKee, Martin, et al.
Publicado: (2021)

Therapeutic Monitoring of Direct Oral Anticoagulants—Back to the Future?
por: Hu, Kai, et al.
Publicado: (2020)

Stresses and anxieties in the time of the COVID-19 pandemic — what we can learn
por: Ayyala, Rama S., et al.
Publicado: (2020)

Emotions and decisions in the real world: What can we learn from quasi-field experiments?
por: Bhanot, Syon P., et al.
Publicado: (2020)

Oral Anticoagulant Therapy: When What Should Not Be Is and What Should Be Is Not
por: Reiffel, James A.
Publicado: (2019)

Bosentan and oral anticoagulants in HIV patients: what we can learn of cases reported so far
por: Morales-Molina, José Antonio, et al.
Publicado: (2011)

Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants
por: Meid, Andreas D., et al.
Publicado: (2021)

Randomized COVID-19 vaccination rollout can offer direct real-world evidence
por: Hemkens, Lars G., et al.
Publicado: (2021)

Solving the worldwide emergency department crowding problem – what can we learn from an Israeli ED?
por: Pines, Jesse M., et al.
Publicado: (2015)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
por: Takatsuki, Seiji, et al.
Publicado: (2017)

What can we do about osteoarthritis?
por: Lohmander, L Stefan
Publicado: (2000)

Blood management in intensive care medicine: CRIT and ABC – what can we learn?
por: Spahn, Donat R, et al.
Publicado: (2004)

Analyzing Policies Through a DOHaD Lens: What Can We Learn?
por: Goodman, Julia M., et al.
Publicado: (2018)

Direct oral anticoagulants in extremely obese patients: OK to use?
por: Moll, Stephan, et al.
Publicado: (2018)

Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice
por: Roberti, Roberta, et al.
Publicado: (2021)

Determinants and disparities in oral anticoagulation prescription: We are far from the PINNACLE of care
por: Modaff, Daniel S., et al.
Publicado: (2022)

Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
por: Hoffer, Edward P.
Publicado: (2021)

Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
por: Gustafson, Whitney L., et al.
Publicado: (2019)

Suicide epidemic in Malawi: what can we do?
por: Banda, Gift Treighcy, et al.
Publicado: (2021)

Hematohepatology: The potential for direct oral anticoagulant “Inflation” in liver transplant candidates
por: Schaefer, Jordan K., et al.
Publicado: (2023)

What can we learn from mixed neuroglial primary cultures about the impact of inflammation on the afferent somatosensory system?
por: Braun, Hans Albert
Publicado: (2020)

What will we choose to learn from the COVID-19 pandemic?
por: Bayingana, Alice Uwase, et al.
Publicado: (2021)

Assessing outcomes of health and medical research: do we measure what counts or count what we can measure?
por: Wells, Robert, et al.
Publicado: (2007)

Can we do for other essential medicines what we are doing for the COVID-19 vaccine?
por: Murphy, Adrianna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4vv9eb5bl5o38pi3jdgq21e8ac